COMMUNIQUÉS West-GlobeNewswire

BioAro launches AI-Driven PanOmiQ with Ultrafast Whole Genome Sequencing Analysis Technology
03/02/2025
Transforming Genomic Medicine with Unprecedented Speed, Accuracy, and Accessibility - PanOmiQ Sets a New Standard with Analysis Time from VCF Files Under 5 Minutes, and Less Than 2 hrs for FASTQ Files CALGARY, Alberta, [...]
Chronic Pain Centre of Excellence for Canadian Veterans and Bayshore HealthCare Unite to Support Veterans at Invictus Games Vancouver Whistler 2025
03/02/2025
HAMILTON, Ontario, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Chronic Pain Centre of Excellence for Canadian Veterans (CPCoE) is excited to announce its attendance at the Invictus Games Vancouver Whistler 2025 presented by [...]
Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens et Bayshore HealthCare s’unissent pour appuyer les vétérans et les Jeux Invictus Vancouver Whistler 2025
03/02/2025
HAMILTON, Ontario, 03 févr. 2025 (GLOBE NEWSWIRE) -- Le Centre d’excellence sur la douleur chronique pour les vétérans canadiens (CESLDC) est heureux d’annoncer sa présence aux Jeux Invictus Vancouver Whistler 2025 [...]
BioAdaptives Welcomes Mark Frissora, Acclaimed Business Leader, to Its Board of Directors
03/02/2025
Frissora is recognized for his ability to lead organizations through complex challenges and deliver sustained value creation LAS VEGAS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BioAdaptives, Inc. (OTC: BDPT), a pioneering [...]
King Faisal Specialist Hospital & Research Centre Ranks 15th Globally
03/02/2025
Maintaining its Leadership in the Middle East and North Africa RIYADH, Saudi Arabia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- In an unprecedented achievement reflecting its excellence in specialized healthcare and medical [...]
PacBio Announces Appointment of David Ruggiero as Head of Global Sales & Service
03/02/2025
MENLO PARK, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ: PACB), a leading developer of high-quality, highly accurate sequencing solutions, today announced the appointment of David Ruggiero as the company’s [...]
Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025
03/02/2025
SAN JOSE, Calif., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Outset Medical, Inc. (Nasdaq: OM) (“Outset”), a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis, [...]
Procaps Group Receives Delisting Notice From Nasdaq
03/02/2025
MIAMI and BARRANQUILLA, Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Procaps Group, S.A. (NASDAQ: PROC) (“Procaps” or the “Company”), a leading integrated LatAm healthcare and pharmaceutical services company, today [...]
Orchard Therapeutics Announces Multiple Data Presentations and Receives 2025 New Treatment Award at the 21st Annual WORLDSymposium™
03/02/2025
Featured data showcase the transformative potential of HSC gene therapy to enable cross-correction and restore enzymatic function in a variety of tissues and organs, including the CNS TOKYO, LONDON and BOSTON, Feb. 03, [...]
Adia Nutrition Officially Enters $15.1 Billion Global Stem Cell Market with Domestic Treatments by Successful Opening of First Florida Location
03/02/2025
WINTER PARK, Fla., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Adia Nutrition Inc. (OTC Pink: ADIA), through its medical division Adia Med, is strategically positioning itself to capture a significant share of the growing $15.1 [...]
MedBright AI Appointments Brandon Kou as Director
03/02/2025
VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- MedBright AI Investments Inc. (the “ Company ” or “ MedBright AI ”) (CSE:MBAI, OTCQB:MBAIF, FSE:Y30) is pleased to announce that Brandon Kou has joined [...]
Safety Shot, Inc. Terminates At-the-Market Equity Offering, Reaffirms Strong Financial Position and Growth Trajectory
03/02/2025
SCOTTSDALE, Ariz., Feb. 03, 2025 (GLOBE NEWSWIRE) -- Safety Shot, Inc. (Nasdaq: SHOT) ("Safety Shot" or the "Company"), a leading wellness and dietary supplement company, today announced the termination of its at-the- [...]
Mangoceuticals, Inc. Executes Exclusive Distribution Agreement with Propre Energie for Clinically Proven Dermytol®️ Skincare Treatment Targeting Hyperpigmentation
03/02/2025
Dallas, TX & Quebec, Canada, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (NASDAQ: MGRX), a company focused on developing, marketing, and selling a variety of men’s wellness products and services via a [...]
Nexalin’s Breakthrough DIFS™ Neurostimulation Device Demonstrates Reduction in Blood Pressure while Enhancing Mental Health According to New Landmark Study
03/02/2025
HOUSTON, TX, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Nexalin Technology, Inc. (Nasdaq: NXL; NXLIW) (the “Company” or “Nexalin”) the leader in Deep Intracranial Frequency Stimulation (DIFS™) of the brain, announces the [...]
Tenaya Therapeutics Receives $8 Million Clinical Grant from California Institute for Regenerative Medicine
03/02/2025
Funding will Support Ongoing RIDGE™ -1 Clinical Trial of TN-401 Gene Therapy for the Potential Treatment of PKP2-Associated Arrhythmogenic Right Ventricular Cardiomyopathy Initial Data from RIDGE-1 Phase 1b Clinical [...]
Annovis Bio, Inc. Announces Proposed Public Offering
01/02/2025
MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) -- via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for [...]
Beta Bionics Announces Closing of $234.6 Million Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
31/01/2025
IRVINE, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- Beta Bionics, Inc. (Nasdaq: BBNX), a pioneering leader in the development of advanced diabetes management solutions, today announced the closing of its upsized initial [...]
The Ensign Group Schedules Year End 2024 Earnings Call for Thursday, February 6, 2025
31/01/2025
SAN JUAN CAPISTRANO, Calif., Jan. 31, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Evaxion announces closing of $10.8 million public offering
31/01/2025
COPENHAGEN, Denmark, January 31, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, today announced the closing of a [...]

Pages